PGY vs. NKTR

Last updated Apr 2, 2026

Compare and contrast key facts about Pagaya Technologies Ltd. (PGY) and Nektar Therapeutics (NKTR).

Performance

PGY vs. NKTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pagaya Technologies Ltd. (PGY) and Nektar Therapeutics (NKTR). The values are adjusted to include any dividend payments, if applicable.

PGY vs. NKTR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
PGY Pagaya Technologies Ltd.	-44.02%	124.97%	-43.90%	11.29%	-79.61%
NKTR Nektar Therapeutics	79.07%	203.08%	64.60%	-75.00%	-45.67%

Fundamentals

Market Cap PGY : $1.19B NKTR : $1.54B
EPS PGY : $0.90 NKTR : -$10.15
PS Ratio PGY : 0.84 NKTR : 22.15
PB Ratio PGY : 2.48 NKTR : 17.11
Total Revenue (TTM) PGY : $1.26B NKTR : $55.23M
Gross Profit (TTM) PGY : $512.17M NKTR : $55.04M
EBITDA (TTM) PGY : $192.27M NKTR : -$122.97M

Returns By Period

In the year-to-date period, PGY achieves a -44.02% return, which is significantly lower than NKTR's 79.07% return.

PGY

• 1D: 0.43%
• 1M: 3.17%
• YTD: -44.02%
• 6M: -60.88%
• 1Y: 10.80%
• 3Y*: -1.49%
• 5Y*: —
• 10Y*: —

NKTR

• 1D: 5.23%
• 1M: 10.75%
• YTD: 79.07%
• 6M: 28.65%
• 1Y: 691.99%
• 3Y*: 92.93%
• 5Y*: -24.37%
• 10Y*: -9.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PGY vs. NKTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PGY

PGY Risk / Return Rank: 46
PGY Sharpe Ratio Rank: 45
PGY Sortino Ratio Rank: 50
PGY Omega Ratio Rank: 48
PGY Calmar Ratio Rank: 44
PGY Martin Ratio Rank: 44

NKTR

NKTR Risk / Return Rank: 99
NKTR Sharpe Ratio Rank: 98
NKTR Sortino Ratio Rank: 99
NKTR Omega Ratio Rank: 98
NKTR Calmar Ratio Rank: 99
NKTR Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PGY vs. NKTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pagaya Technologies Ltd. (PGY) and Nektar Therapeutics (NKTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PGY	NKTR	Difference
Sharpe ratio Return per unit of total volatility	0.13	3.69	-3.56
Sortino ratio Return per unit of downside risk	0.83	5.91	-5.08
Omega ratio Gain probability vs. loss probability	1.10	1.67	-0.57
Calmar ratio Return relative to maximum drawdown	0.15	13.80	-13.65
Martin ratio Return relative to average drawdown	0.30	33.65	-33.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PGY vs. NKTR - Sharpe Ratio Comparison

The current PGY Sharpe Ratio is 0.13, which is lower than the NKTR Sharpe Ratio of 3.69. The chart below compares the historical Sharpe Ratios of PGY and NKTR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PGY	NKTR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.13	3.69	-3.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.20	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.10	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.26	0.01	-0.27

Correlation

The correlation between PGY and NKTR is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PGY vs. NKTR - Dividend Comparison

Neither PGY nor NKTR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PGY vs. NKTR - Drawdown Comparison

The maximum PGY drawdown since its inception was -98.09%, roughly equal to the maximum NKTR drawdown of -99.61%. Use the drawdown chart below to compare losses from any high point for PGY and NKTR.

Drawdown Indicators

	PGY	NKTR	Difference
Max Drawdown Largest peak-to-trough decline	-98.09%	-99.61%	+1.52%
Max Drawdown (1Y) Largest decline over 1 year	-75.71%	-46.54%	-29.17%
Max Drawdown (5Y) Largest decline over 5 years	—	-97.93%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.61%	—
Current Drawdown Current decline from peak	-96.74%	-95.35%	-1.39%
Average Drawdown Average peak-to-trough decline	-91.80%	-68.17%	-23.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	39.17%	19.09%	+20.08%

Volatility

PGY vs. NKTR - Volatility Comparison

Pagaya Technologies Ltd. (PGY) and Nektar Therapeutics (NKTR) have volatilities of 17.79% and 17.64%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PGY	NKTR	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.79%	17.64%	+0.15%
Volatility (6M) Calculated over the trailing 6-month period	57.75%	65.68%	-7.93%
Volatility (1Y) Calculated over the trailing 1-year period	84.56%	189.39%	-104.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	147.44%	121.48%	+25.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	147.44%	96.96%	+50.48%

Financials